These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 8109993)
1. [Experimental study on the effectiveness of PET tumor images for cancer diagnosis]. Yoshioka T; Takahashi H; Oikawa H; Kanamaru R Gan To Kagaku Ryoho; 1994 Feb; 21(3):369-73. PubMed ID: 8109993 [TBL] [Abstract][Full Text] [Related]
2. Influence of chemotherapy on FDG uptake by human cancer xenografts in nude mice. Yoshioka T; Takahashi H; Oikawa H; Maeda S; Ido T; Akaizawa T; Fukuda H; Kanamaru R J Nucl Med; 1997 May; 38(5):714-7. PubMed ID: 9170434 [TBL] [Abstract][Full Text] [Related]
3. Accumulation of 2-deoxy-2[18F]fluoro-D-glucose in human cancers heterotransplanted in nude mice: comparison between histology and glycolytic status. Yoshioka T; Takahashi H; Oikawa H; Maeda S; Wakui A; Watanabe T; Tezuka F; Takahashi T; Ido T; Kanamaru R J Nucl Med; 1994 Jan; 35(1):97-103. PubMed ID: 8271070 [TBL] [Abstract][Full Text] [Related]
4. New approach to clinical evaluation of cancer chemotherapy using positron emission tomography with 18FDG (2-deoxy-2-[18F]fluoro-D-glucose). Takahashi H; Yamaguchi K; Wakui A; Maeda S; Yang PK; Ito M; Matsuzawa T; Fukuda H; Ido T Sci Rep Res Inst Tohoku Univ Med; 1986 Dec; 33(1-4):38-43. PubMed ID: 3498212 [No Abstract] [Full Text] [Related]
5. Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization. Vitola JV; Delbeke D; Meranze SG; Mazer MJ; Pinson CW Cancer; 1996 Nov; 78(10):2216-22. PubMed ID: 8918417 [TBL] [Abstract][Full Text] [Related]
6. Clinical assessment of therapeutic effects on cancer using 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography: preliminary study of lung cancer. Abe Y; Matsuzawa T; Fujiwara T; Itoh M; Fukuda H; Yamaguchi K; Kubota K; Hatazawa J; Tada M; Ido T Int J Radiat Oncol Biol Phys; 1990 Oct; 19(4):1005-10. PubMed ID: 2170302 [TBL] [Abstract][Full Text] [Related]
7. Comparison of 2- and 3-18F-fluoro-deoxy-D-glucose for studies of tissue metabolism. Kearfott KJ; Elmaleh DR; Goodman M; Correia JA; Alpert NM; Ackerman RH; Brownell GL; Strauss WH Int J Nucl Med Biol; 1984; 11(1):15-22. PubMed ID: 6610664 [TBL] [Abstract][Full Text] [Related]
8. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury. Ogawa T; Kanno I; Shishido F; Inugami A; Higano S; Fujita H; Murakami M; Uemura K; Yasui N; Mineura K Acta Radiol; 1991 May; 32(3):197-202. PubMed ID: 2064862 [TBL] [Abstract][Full Text] [Related]
9. Imaging of renal cancer using positron emission tomography with 2-deoxy-2-(18F)-fluoro-D-glucose: pilot animal and human studies. Wahl RL; Harney J; Hutchins G; Grossman HB J Urol; 1991 Dec; 146(6):1470-4. PubMed ID: 1942320 [TBL] [Abstract][Full Text] [Related]
10. [Positron-emission tomography: role of 18F-fluorodeoxyglucose (18FDG) imaging in oncology]. Lagrange JL; Maublant J; Darcourt J Bull Cancer; 1995 Aug; 82(8):611-22. PubMed ID: 7492817 [TBL] [Abstract][Full Text] [Related]
11. PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine. Haberkorn U; Bellemann ME; Altmann A; Gerlach L; Morr I; Oberdorfer F; Brix G; Doll J; Blatter J; van Kaick G J Nucl Med; 1997 Aug; 38(8):1215-21. PubMed ID: 9255154 [TBL] [Abstract][Full Text] [Related]
12. Imaging metastatic testicular germ cell tumours with 18FDG positron emission tomography: prospects for detection and management. Wilson CB; Young HE; Ott RJ; Flower MA; Cronin BF; Pratt BE; McCready VR; Horwich A Eur J Nucl Med; 1995 Jun; 22(6):508-13. PubMed ID: 7556294 [TBL] [Abstract][Full Text] [Related]